Literature DB >> 7635027

"Talking about drug treatments--who should say what to whom?"--the second DTB symposium.

.   

Abstract

Information about medicines is as important as the quality of the medicines themselves. Without sufficient, accurate and understandable information the doctor cannot decide on the best treatment regimen to offer and ultimately the patient cannot decide what treatment to accept. The second annual Drug and Therapeutics Bulletin symposium, held in March, considered the provision of information, its production and distribution, and the legal, ethical and professional codes by which it is shaped. These issues were addressed by Ian Dodds-Smith (legal aspects), Nick Barber (pharmacy matters), Bonnie Sibbald (communication between hospital and general practice), Barbara Altounyan (the media), David Dickinson and Marianne Rigge (consumers), Gwen Parr and Justin Greenwood (the pharmaceutical industry) and Joe Collier (provision of consensus advice). The audience also made important contributions.

Entities:  

Mesh:

Year:  1994        PMID: 7635027     DOI: 10.1136/dtb.1994.32535

Source DB:  PubMed          Journal:  Drug Ther Bull        ISSN: 0012-6543


  2 in total

1.  [Response of the pharmaceutical industry to a specific consultation].

Authors:  I Vázquez Gómez; F Fernández-Llimos; M A Gastelurrutia
Journal:  Aten Primaria       Date:  2005-03-15       Impact factor: 1.137

2.  Information provided by generic and brand-name pharmaceutical manufacturers in response to a request.

Authors:  Fernando Fernandez-Llimos; Isabel Vazquez Gomez
Journal:  Pharm World Sci       Date:  2007-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.